| Execution period | 5 months |
|---|
NSE filing, NSE: SAKAR. Summary written from the filing by ALFA Finder's alert engine.
Sakar Healthcare Ltd: key numbers
- Share price
- ₹944.80
- Market cap
- ₹2,102 Cr
- Revenue (annual)
- ₹251.7 Cr
- Net profit (annual)
- ₹30.48 Cr
- P/E (TTM)
- 49.0×Sector 45.9×
- Promoter holding
- 51.70%-0.82% QoQ
- FII holding
- 12.34%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sakar Healthcare Ltd
All →Sakar Healthcare Earnings Call Transcript: Key Takeaways
Sakar Healthcare delivered exceptional growth as its oncology segment scales, with EBITDA doubling and margins expanding significantly due to product-mix shifts. Management is pivoting from a non-oncology focus to high-margin oncology formulations and APIs.
- Call
- Guides 35% growth
Sakar Healthcare Investor Presentation: Key Takeaways
Q2FY27 consolidated revenue Rs87.4 Cr (+52% YoY), EBITDA Rs24.4 Cr (28% margin), PAT Rs11.3 Cr (+149%); pitch centres on oncology integration.
Sakar Healthcare Results Update
Sakar Healthcare reported Q2 FY27 revenue of ₹87.42 Cr and PAT of ₹11.31 Cr, up 149% YoY. EBITDA rose 114% to ₹24.35 Cr on strong oncology approvals and commercial supply commencement.
Sakar Healthcare Q2 FY27 Results: Net Profit ₹11.3 Cr, Up 151.1% YoY
Sakar Healthcare Ltd reported revenue from operations of ₹87.4 Cr (+51.7% YoY) and net profit of ₹11.3 Cr (+151.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹11.3 Cr · +151.1% YoY
Sakar Healthcare Board Meeting Date
Sakar Healthcare has scheduled a board meeting for October 23, 2026, to approve its unaudited quarterly financial results for the period ended September 2026.
Sakar Healthcare Business Update
Sakar Healthcare says its oncology export model is expanding, with 22 Marketing Authorizations granted and commercial supply starting from its EU GMP site. No monetary value stated.
Other management change announcements
All →Next Mediaworks Management Change
Next Mediaworks disclosed that CEO and KMP Rohit Kalra resigned effective close of business on 31 October 2026. The resignation has no bearing on the holding company or the group's radio operations.
Canara HSBC Life Insurance Company Management Change
Canara HSBC Life appointed Sunil Kumar Chugh as Additional Non-Executive Non-Independent Director, effective 5 November 2026. The appointment is subject to shareholder approval.
Mangal Electrical Industries Management Change
Mangal Electrical appointed Swathirajan Mulvadi Gomadam as Chief Operating Officer-CRGO, effective 31 October 2026. The appointment was approved at a board meeting that day.
Dixon Technologies (India) Management Change
Dixon Technologies appointed Prithvi Vachani as Additional Director (Executive Director) for 60 months, effective 30 October 2026. He is the son of Executive Chairman Sunil Vachani.
- Execution
- 60 months
Global Health Management Change
Senior management personnel Dr Pankaj Dhamija, Gurugram Hospital Director, resigned with last working day 30 October 2026. He was relieved earlier than his contractual December 2026 date.
Eleganz Interiors Management Change
Eleganz Interiors reported resignations of CFO Mayank Kumar Sharmna and COO Archana Desai, effective 1 November 2026. Nehal Mehta and Aditya Shah are appointed as CFO and COO respectively from the same date.